Search

Your search keyword '"de Boer, Jan"' showing total 76 results

Search Constraints

Start Over You searched for: Author "de Boer, Jan" Remove constraint Author: "de Boer, Jan" Topic mesenchymal stem cells Remove constraint Topic: mesenchymal stem cells
76 results on '"de Boer, Jan"'

Search Results

1. Expanding Biomaterial Surface Topographical Design Space through Natural Surface Reproduction.

2. Discovery of synergistic material-topography combinations to achieve immunomodulatory osteoinductive biomaterials using a novel in vitro screening method: The ChemoTopoChip.

3. On the correlation between material-induced cell shape and phenotypical response of human mesenchymal stem cells.

4. Mechanotransduction is a context-dependent activator of TGF-β signaling in mesenchymal stem cells.

5. Ectopic bone formation by aggregated mesenchymal stem cells from bone marrow and adipose tissue: A comparative study.

6. Micro-Topographies Promote Late Chondrogenic Differentiation Markers in the ATDC5 Cell Line.

7. Collagen modules for in situ delivery of mesenchymal stromal cell-derived endothelial cells for improved angiogenesis.

8. A relativity concept in mesenchymal stromal cell manufacturing.

9. Spatial distribution and survival of human and goat mesenchymal stromal cells on hydroxyapatite and β-tricalcium phosphate.

10. Coculturing Human Islets with Proangiogenic Support Cells to Improve Islet Revascularization at the Subcutaneous Transplantation Site.

11. MicroRNA Levels as Prognostic Markers for the Differentiation Potential of Human Mesenchymal Stromal Cell Donors.

12. Spatiotemporal proliferation of human stromal cells adjusts to nutrient availability and leads to stanniocalcin-1 expression in vitro and in vivo.

13. Organizational metrics of interchromatin speckle factor domains: integrative classifier for stem cell adhesion & lineage signaling.

14. Analysis of high-throughput screening reveals the effect of surface topographies on cellular morphology.

15. Boosting angiogenesis and functional vascularization in injectable dextran-hyaluronic acid hydrogels by endothelial-like mesenchymal stromal cells.

16. Suppression of the immune system as a critical step for bone formation from allogeneic osteoprogenitors implanted in rats.

17. The effect of donor variation and senescence on endothelial differentiation of human mesenchymal stromal cells.

18. Insulin-like growth factor-I enhances proliferation and differentiation of human mesenchymal stromal cells in vitro.

19. Molecular mechanisms of biomaterial-driven osteogenic differentiation in human mesenchymal stromal cells.

20. Predicting the therapeutic efficacy of MSC in bone tissue engineering using the molecular marker CADM1.

21. Effect of antioxidant supplementation on the total yield, oxidative stress levels, and multipotency of bone marrow-derived human mesenchymal stromal cells.

22. A small molecule approach to engineering vascularized tissue.

23. Engineering new bone via a minimally invasive route using human bone marrow-derived stromal cell aggregates, microceramic particles, and human platelet-rich plasma gel.

24. Diverse effects of cyclic AMP variants on osteogenic and adipogenic differentiation of human mesenchymal stromal cells.

25. A calcium-induced signaling cascade leading to osteogenic differentiation of human bone marrow-derived mesenchymal stromal cells.

26. Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements.

27. Forskolin enhances in vivo bone formation by human mesenchymal stromal cells.

28. Endothelial differentiation of mesenchymal stromal cells.

29. A mesenchymal stromal cell gene signature for donor age.

30. An algorithm-based topographical biomaterials library to instruct cell fate.

31. Pro-osteogenic trophic effects by PKA activation in human mesenchymal stromal cells.

32. Differential bone-forming capacity of osteogenic cells from either embryonic stem cells or bone marrow-derived mesenchymal stem cells.

33. High-throughput assay for the identification of compounds regulating osteogenic differentiation of human mesenchymal stromal cells.

34. Timing, rather than the concentration of cyclic AMP, correlates to osteogenic differentiation of human mesenchymal stem cells.

35. The effect of PKC activation and inhibition on osteogenic differentiation of human mesenchymal stem cells.

36. ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation.

37. Endogenous collagen influences differentiation of human multipotent mesenchymal stromal cells.

38. Effect of chordin-like 1 on MC3T3-E1 and human mesenchymal stem cells.

39. The role of collagen crosslinking in differentiation of human mesenchymal stem cells and MC3T3-E1 cells.

40. The effect of bone marrow aspiration strategy on the yield and quality of human mesenchymal stem cells.

41. cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo.

42. The response of human mesenchymal stem cells to osteogenic signals and its impact on bone tissue engineering.

43. Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering.

44. A rapid and efficient method for expansion of human mesenchymal stem cells.

45. Inhibition of histone acetylation as a tool in bone tissue engineering.

46. Fiber diameter and texture of electrospun PEOT/PBT scaffolds influence human mesenchymal stem cell proliferation and morphology, and the release of incorporated compounds.

47. Endothelial cells assemble into a 3-dimensional prevascular network in a bone tissue engineering construct.

48. Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cells.

50. Micro‐Topographies Induce Epigenetic Reprogramming and Quiescence in Human Mesenchymal Stem Cells.

Catalog

Books, media, physical & digital resources